Last reviewed · How we verify
Gabapentin 400 mg
Gabapentin 400 mg is a Small molecule drug developed by Mit Ghamr Oncology Center. It is currently FDA-approved.
At a glance
| Generic name | Gabapentin 400 mg |
|---|---|
| Sponsor | Mit Ghamr Oncology Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine. (PHASE4)
- Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome (PHASE4)
- Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery (PHASE3)
- The Effect of Oral Gabapentin on Emergence Agitation and Delirium in Adult Patients After Nasal Surgery. (PHASE3)
- Preventive Approach Using Venlafaxine (PHASE4)
- Preoperative Gabapentin for Chronic Pain After Thoracotomy (GABATHOMIE). (PHASE3)
- Pregabalin Versus Gabapentin Opioid Sparing Effect in Discectomy (PHASE3)
- Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Gabapentin 400 mg CI brief — competitive landscape report
- Gabapentin 400 mg updates RSS · CI watch RSS
- Mit Ghamr Oncology Center portfolio CI
Frequently asked questions about Gabapentin 400 mg
What is Gabapentin 400 mg?
Gabapentin 400 mg is a Small molecule drug developed by Mit Ghamr Oncology Center.
Who makes Gabapentin 400 mg?
Gabapentin 400 mg is developed and marketed by Mit Ghamr Oncology Center (see full Mit Ghamr Oncology Center pipeline at /company/mit-ghamr-oncology-center).
What development phase is Gabapentin 400 mg in?
Gabapentin 400 mg is FDA-approved (marketed).
Related
- Manufacturer: Mit Ghamr Oncology Center — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing